Again, the analysis of gp130 and phospho‐STAT3 co‐expression in our patient cohort confirmed that active STAT3 is more commonly (but not exclusively) observed in gp130‐expressing DLBCL. The gene discussed is STAT3; the disease is diffuse large B-cell lymphoma.